Nature Biotechnology 2004 Peter Mitchell - Abstracts
| Nature Biotechnology 2004 Peter Mitchell | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Bioinformatics attracts big guns. | Business | Peter Mitchell | |||
| Biotech holds steady in Q4. | Business | Peter Mitchell | |||
| Cash-strapped biotechs find financing alternative. | Business | Peter Mitchell | |||
| Celltech acquisition sends mixed messages. | Business | Peter Mitchell | |||
| Erbitux diagnostic latest adjunct to cancer therapy. | Business | Peter Mitchell | |||
| Erbitux diagnostic latest adjunct to cancer therapy. | Business | Peter Mitchell | |||
| International regional collaborations are paying off. | Business | Peter Mitchell | |||
| Sanofi takeover jeopardizes Aventis biotech deals. | Business | Peter Mitchell | |||
| The changing attitude of European VCs.(venture capitalists ) | Business | Peter Mitchell | |||
| UK urged to plug "bioprocessing gap". | Business | Peter Mitchell | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.